Abstract

BackgroundEndometrial stem/progenitor cells contribute to the cyclical regeneration of human endometrium throughout a woman's reproductive life. Although the candidate cell populations have been extensively studied, no consensus exists regarding which endometrial population represents the stem/progenitor cell fraction in terms of in vivo stem cell activity. We have previously reported that human endometrial side population cells (ESP), but not endometrial main population cells (EMP), exhibit stem cell-like properties, including in vivo reconstitution of endometrium-like tissues when xenotransplanted into immunodeficient mice. The reconstitution efficiency, however, was low presumably because ESP cells alone could not provide a sufficient microenvironment (niche) to support their stem cell activity. The objective of this study was to establish a novel in vivo endometrial stem cell assay employing cell tracking and tissue reconstitution systems and to examine the stem cell properties of ESP through use of this assay.Methodology/Principal FindingsESP and EMP cells isolated from whole endometrial cells were infected with lentivirus to express tandem Tomato (TdTom), a red fluorescent protein. They were mixed with unlabeled whole endometrial cells and then transplanted under the kidney capsule of ovariectomized immunodeficient mice. These mice were treated with estradiol and progesterone for eight weeks and nephrectomized. All of the grafts reconstituted endometrium-like tissues under the kidney capsules. Immunofluorescence revealed that TdTom-positive cells were significantly more abundant in the glandular, stromal, and endothelial cells of the reconstituted endometrium in mice transplanted with TdTom-labeled ESP cells than those with TdTom-labeled EMP cells.Conclusions/SignificanceWe have established a novel in vivo endometrial stem cell assay in which multi-potential differentiation can be identified through cell tracking during in vivo endometrial tissue reconstitution. Using this assay, we demonstrated that ESP cells differentiated into multiple endometrial lineages in the niche provided by whole endometrial cells, indicating that ESP cells are genuine endometrial stem/progenitor cells.

Highlights

  • Human endometrium lines the uterine cavity and regenerates, differentiates and regresses with each menstrual cycle under hormonal control throughout the course of a woman’s reproductive life [1]

  • It is likely that the cyclical regeneration of human endometrium is achieved through tissuespecific stem cell system(s) in which human endometrium contains a pool of multipotent stem cells capable of cyclically producing progenitor cells that further differentiate into each endometrial cell component [3,4]

  • We previously demonstrated that side population (SP) cells, but not main population (MP) cells, both isolated from the human endometrium, regenerate human endometriumlike tissues in vivo when xenotransplanted under the kidney capsule of NOG mice [10]

Read more

Summary

Introduction

Human endometrium lines the uterine cavity and regenerates, differentiates and regresses with each menstrual cycle under hormonal control throughout the course of a woman’s reproductive life [1]. These morphological and functional features of human endometrium can be reproduced in an in vivo endometrial regeneration model in which severely immunodeficient NOD/SCID/ccnull (NOG) mice are xenotransplanted with dispersed human endometrial cells under the kidney capsule followed by hormonal treatment [2]. The candidate cell populations have been extensively studied, no consensus exists regarding which endometrial population represents the stem/progenitor cell fraction in terms of in vivo stem cell activity. The objective of this study was to establish a novel in vivo endometrial stem cell assay employing cell tracking and tissue reconstitution systems and to examine the stem cell properties of ESP through use of this assay

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call